Identification of Differentially Expressed Proteins in Triple-Negative Breast Carcinomas Using DIGE and Mass Spectrometry-Reference-Cited by-同舟云学术

Identification of Differentially Expressed Proteins in Triple-Negative Breast Carcinomas Using DIGE and Mass Spectrometry

Published:2009-06-12 Issue:7 Volume:8 Page:3430-3438
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Schulz Daniela M.¹,Böllner Claudia¹,Thomas Gerry¹,Atkinson Mike¹,Esposito Irene¹,Höfler Heinz¹,Aubele Michaela¹

Affiliation:

1. Institute of Pathology, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstädter Landstrasse 1, 85764 Neuherberg, Germany, Molecular Pathology, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom, Institute of Radiation Biology, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstädter Landstrasse 1, 85764 Neuherberg, Germany, Klinik und Poliklinik für Strahlentherapie, Klinikum rechts der Isar,...

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/pr900071h

Reference51 articles.

1. High prevalence of triple-negative tumors in an urban cancer center

2. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype

3. Concurrent chemo-radiation in the conservative management of breast cancer

4. Molecular portraits of human breast tumours

5. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bibliometric analysis of phosphoglycerate kinase 1 expression in breast cancer and its distinct upregulation in triple-negative breast cancer;World Journal of Clinical Oncology;2024-07-24

2. A Rare Variant in MDH2 (rs111879470) Is Associated with Predisposition to Recurrent Breast Cancer in an Extended High-Risk Pedigree;Cancers;2023-12-15

3. Functional impact of multi-omic interactions in breast cancer subtypes;Frontiers in Genetics;2023-01-05

4. Transforming Diagnosis and Therapeutics Using Cancer Genomics;Therapeutic Approaches in Cancer Treatment;2023

5. ‘Breast Cancer Resistance Likelihood and Personalized Treatment Through Integrated Multiomics’;Frontiers in Molecular Biosciences;2022-04-14